Medicare Enrolled
Dr. Debra Reich-Sobel, DO
Family Medicine · Linden, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reich-Sobel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reich-Sobel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reich-Sobel
Dr. Debra Reich-Sobel is a family medicine specialist in Linden, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Reich-Sobel performed 1,979 Medicare services across 873 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reich-Sobel received a total of $9,287 from 58 pharmaceutical and/or device companies across 692 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reich-Sobel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 12% volume in NJ
$9,287 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,979
Medicare services
Top 12% in NJ for family medicine
873
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~104 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
483 | $64 | $112 |
| Home visit, established patient, low complexity A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes. |
328 | $61 | $135 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
254 | $103 | $205 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
247 | $72 | $122 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
208 | $107 | $179 |
| Home visit, established patient, straightforward decision making A home visit for an established patient involving straightforward medical decision making. The visit lasts at least 15 minutes when time is used to determine the level of service. |
54 | $35 | $90 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
50 | $45 | $75 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
48 | $140 | $200 |
| Home visit, new patient, moderate complexity A home visit for a new patient involving moderate medical decision making, lasting at least 60 minutes. |
46 | $113 | $291 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
42 | $159 | $269 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
35 | $29 | $30 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
34 | $43 | $90 |
| Home health agency supervision, complex multidisciplinary care Supervision by a physician or allowed practitioner for a patient receiving Medicare-covered services from a participating home health agency. This involves complex and multidisciplinary care modalities, with the patient not present during the supervision. |
34 | $89 | $175 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
32 | $11 | $65 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
29 | $74 | $86 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
21 | $13 | $45 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
21 | $1 | $10 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
13 | $92 | $182 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,287
Total received (2018-2024)
Avg $1,327/year across 7 years
Top 5% in NJ for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
692
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,262 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$25 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,082
2023
$1,854
2022
$1,516
2021
$1,690
2020
$591
2019
$1,269
2018
$1,285
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Corcept Therapeutics
$303
Lilly USA, LLC
$125
ABBVIE INC.
$83
Otsuka America Pharmaceutical, Inc.
$72
Bayer Healthcare Pharmaceuticals Inc.
$66
AstraZeneca Pharmaceuticals LP
$61
Astellas Pharma US Inc
$56
Novo Nordisk Inc
$38
AERIN MEDICAL INC.
$35
Lundbeck LLC
$34
GlaxoSmithKline, LLC.
$31
Paratek Pharmaceuticals, Inc.
$29
SCILEX PHARMACEUTICALS INC.
$26
Dexcom, Inc.
$19
Novartis Pharmaceuticals Corporation
$18
Exact Sciences Corporation
$17
IDORSIA PHARMACEUTICALS US INC
$15
Acella Pharmaceuticals, LLC
$14
Currax Pharmaceuticals LLC
$14
PFIZER INC.
$14
Merck Sharp & Dohme LLC
$14
Top 3 companies account for 47.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,339
Lilly USA, LLC
$832
Janssen Pharmaceuticals, Inc
$479
GlaxoSmithKline, LLC.
$462
Corcept Therapeutics
$389
Novartis Pharmaceuticals Corporation
$388
ABBVIE INC.
$374
Sunovion Pharmaceuticals Inc.
$301
PFIZER INC.
$272
AbbVie Inc.
$259
Bayer Healthcare Pharmaceuticals Inc.
$246
Astellas Pharma US Inc
$234
Almatica Pharma LLC
$206
Otsuka America Pharmaceutical, Inc.
$206
Scilex Pharmaceuticals Inc.
$200
AstraZeneca Pharmaceuticals LP
$197
SANOFI-AVENTIS U.S. LLC
$178
Bayer HealthCare Pharmaceuticals Inc.
$176
Merck Sharp & Dohme Corporation
$161
Bausch Health US, LLC
$145
Nevro Corp.
$144
Avanir Pharmaceuticals, Inc.
$140
Amgen Inc.
$133
Kowa Pharmaceuticals America, Inc.
$133
Boehringer Ingelheim Pharmaceuticals, Inc.
$128
Abbott Laboratories
$119
Eisai Inc.
$112
Merck Sharp & Dohme LLC
$106
Teva Pharmaceuticals USA, Inc.
$99
IDORSIA PHARMACEUTICALS US INC
$92
UCB, Inc.
$77
Daiichi Sankyo Inc.
$75
Dexcom, Inc.
$74
Allergan Inc.
$72
Amarin Pharma Inc.
$68
Currax Pharmaceuticals LLC
$61
Biogen, Inc.
$53
DEXCOM, INC.
$49
ARBOR PHARMACEUTICALS, INC.
$44
Exact Sciences Corporation
$43
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$42
AERIN MEDICAL INC.
$35
Lundbeck LLC
$34
Ferring Pharmaceuticals Inc.
$30
Neurelis, Inc.
$30
Paratek Pharmaceuticals, Inc.
$29
Seqirus USA Inc
$28
SCILEX PHARMACEUTICALS INC.
$26
ACADIA Pharmaceuticals Inc
$26
Acorda Therapeutics, Inc
$25
Biohaven Pharmaceutical Holding Company Ltd.
$20
Sumitomo Pharma America, Inc.
$17
Nalpropion Pharmaceuticals LLC
$15
Acella Pharmaceuticals, LLC
$14
Alnylam Pharmaceuticals Inc.
$14
Alexion Pharmaceuticals, Inc.
$14
SUN PHARMACEUTICAL INDUSTRIES INC.
$14
Allergan, Inc.
$11
Top 3 companies account for 28.5% of all-time payments
Associated products mentioned in payments ›
ABILIFY MYCITE · ADUHELM · AJOVY · ANORO · APLENZIN · APTIOM · AUSTEDO · Aimovig · BAQSIMI · BASAGLAR · BELSOMRA · BREO · BREZTRI · BYSTOLIC · Briviact · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · DIFICID · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · Edarbi · Edarbyclor · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fluad · FreeStyle Libre · GEMTESA · GRALISE · Horizant · INBRIJA · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · JYNARQUE · KAPSPARGO · Kerendia · Korlym · LEQVIO · LINZESS · LOKELMA · LONHALA MAGNAIR · LOREEV XR · LYRICA · Livalo · MOUNJARO · MYRBETRIQ · Myrbetriq · NP Thyroid 60 · NUEDEXTA · NUPLAZID · NURTEC ODT · NUZYRA · OFEV · ONPATTRO · Ozempic · PREMARIN · Prolia · QULIPTA · QUVIVIQ · REBYOTA · REXULTI · RYBELSUS · Rybelsus · SERTRALINE HCL · SOLIQUA · SOLIQUA 100/33 · STIOLTO RESPIMAT · Saxenda · Senza Spinal Cord Stimulation System · TOUJEO · TRELEGY ELLIPTA · TRULICITY · Tresiba · UBRELVY · Ultomiris · VALTOCO · VESICARE · VIBERZI · VIVAER STYLUS · VRAYLAR · Vascepa · Veozah · Victoza · WELLBUTRIN · Wegovy · XARELTO · XIFAXAN · XOLAIR · Xultophy 100/3.6 · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for family medicine in NJ.
Geographic Context
Family medicine physicians within 10 mi
2,925
Per 100K population
510.9
County median income
$100,117
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT RAHWAY
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Reich-Sobel is a clinical cardiology specialist, with above-average Medicare volume (top 12% in NJ), with low-engagement industry engagement in the top 5% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Reich-Sobel experienced with nursing facility visit, low complexity?
Based on Medicare claims data, Dr. Reich-Sobel performed 483 nursing facility visit, low complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reich-Sobel receive payments from pharmaceutical companies?
Yes. Dr. Reich-Sobel received a total of $9,287 from 58 companies across 692 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reich-Sobel's costs compare to other family medicine physicians in Linden?
Dr. Reich-Sobel's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reich-Sobel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Linden
Browse family medicine physicians in Linden ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in NJ
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in NJ
Which NJ family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology